Trial Profile
A Study of Second-line Treatment With Apatinib and S-1 in Advanced Hepatocellular Carcinoma Patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Jun 2016
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Gimeracil/oteracil/tegafur
- Indications Liver cancer
- Focus Therapeutic Use
- 25 Jun 2016 New trial record